Archive for November, 2009

Tips For Good Email Mass Marketing Campaign

Email mass marketing is very popular concept to market your business or sales campaign. Everyone uses emails on a regular basis. In fact people are now using email services more often than that of handwritten mailing services.

Gain Best in Class Benefits With Direct Marketing Email

Are you depressed about the dull climate around your business making you feel like stopping it? Are you thinking about different other ways of doing the business as the present one isn't much effective?

Using Autoresponders – How Email Marketing Works to Attract Prospects

The new Attraction Marketing model of internet business is based on 3 basic components. First, your prospects FIND you and what you offer. This is called your Point of Contact marketing. It should consist of more that just a website.

Increasing Your Email Marketing Open Rate

You work hard writing your email content, but why don't people open your marketing emails? Are you giving them a reason to open them?

Business Email List – Key to Market Your Business

Creating a business email list is the most important task that you need to do if you want to market your business online. Internet is the most common and widely used medium and therefore whether you have an ecommerce or online business or still doing your business traditionally or offline you need to market your business on internet to remain competitive.

ChemGenex’s Marketing Authorization Application For Omacetaxine Mepesuccinate Validated By The European Medicines Agency (Medical News Today)

ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.

ChemGenex’s Marketing Authorization Application For Omacetaxine Mepesuccinate Validated By The European Medicines Agency (Medical News Today)

ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.

Email Marketing Systems – Aweber is Perfect For Newbies

Do you want to use one of the very best email marketing systems? Marketing by email is the only way to go with your online business. "The money is in the list."

The Promotional Email Subject Line Must Create Curiosity

Promotional email copy is an important introduction to the sale of a product or service. But, even more critical is the subject line that must entice the reader to actually open the email. Learn a few simple guidelines for creating subject lines that generate results.

Ipsen’s Decapeptyl(R) 6-Month Formulation Receives Marketing Authorization For The Treatment Of Locally Advanced Or … (Medical News Today)

Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate1 22.

« Previous PageNext Page »